INTRODUCTION
Feline immunodeficiency virus (FIV) is a retrovirus of the lentivirus subfamily that causes an immune deficiency syndrome in domestic cats similar in clinical course and pathological features to that observed with acquired immune deficiency syndrome (AIDS) in humans infected with the human immunodeficiency virus type I (HIV-1) (Barlough et al., 1991; Pedersen et al., 1987; Siebelink et al., 1990) . The genome of FIV is closely related to other lentiviruses and encodes the structural and enzymatic genes, gag, pol, and env. In addition, FIV also encodes for three accessory genes: rev, orf A, and vif. All known lentiviruses encode a vif gene, except equine infectious anemia virus (EIAV) and Vif sequences are highly conserved among different isolates of the same virus, suggesting that the vif gene may be important for natural infection. The HIV-1 Vif protein has been found to enhance virus infectivity in producer cells, most likely by modulating virus assembly and/or budding (Fouchier et al., 1996) . Deletion of vif restricts virus replication in target cells at a postentry step leading to reduced reverse transcription of viral RNA (Goncalves et al., 1996; Sova and Volsky, 1993; von Schwedler et al., 1993) , either directly by affecting reverse transcription or indirectly during uncoating or disassembly of the virion core. Importantly, Vif has been shown to be required for efficient HIV-1 replication in vitro in peripheral blood mononuclear cells (PBMCs) and macrophages, primary targets of HIV-1 infection in vivo (Chowdhury et al., 1996; Fan and Peden, 1992; Gabuzda et al., 1994; Kawamura et al., 1994) .
The FIV vif gene is similar in size and genomic location to that of HIV-1-encoded vif (Tomonaga et al., 1992) . Previous studies have shown that FIV vif is required for cell-free infection of feline PBMCs and feline cell lines such as Crandell feline kidney (CrFK), G355-5, and MYA-1 Tomonaga et al., 1992) . However, FIV vif-mutants can productively infect MYA-1 cells when cocultivated with CrFK cells transfected with FIV⌬vif DNA, suggesting that cell-to-cell transmission is not affected by the deletion of the vif gene (Tomonaga et al., 1992) . Moreover, the FIV vif gene is required for efficient viral replication in vivo during the early stage of infection in cats (Inoshima et al., 1996) . Inoshima et al. (1996) reported that inoculation of cats with FIV⌬vif-infected cells resulted in very low viral loads. Nevertheless, the ⌬vif virus was able to replicate in the lymph nodes, presumably by cell-to-cell transmission. In vivo cellular targets of FIV include CD4 ϩ and CD8 ϩ T cells, B cells, and macrophages (Beebe et al., 1994; Dean et al., 1996 Dean et al., , 1999 English et al., 1993) . Early in primary FIV infection, there is a shift from T cells to macrophages as the predominant cellular target, a finding that may be crucial in the pathogenesis of FIV infection (Beebe et al., 1994) . It is, therefore, important to understand the role of FIV vif for virus replication in both PBMCs and macrophages. This report describes a vifmutant of the WT FIV-pPPR clone and examines the role of vif in establishment of cell-free infection in both feline PBMCs and macrophages, as well as in K-258 cells, an interleukin (IL)-2-dependent feline lymphoid cell line.
RESULTS AND DISCUSSION
The FIV-pPPR⌬vif molecular clone was derived from the infectious molecular clone WT FIV-pPPR and encodes for a 375-bp deletion (bases 5530-5330) within the vif gene (Fig. 1) ; presence of the deletion was confirmed by dideoxynucleotide sequencing. To verify expression of structural viral proteins, immunoprecipitation and immunocytochemistry were used to assess expression of FIV p24gag and FIV surface glycoprotein gp100env in CrFK cells transfected with FIV-pPPR⌬vif plasmid DNA. Although nonpermissive for wild-type (WT) FIV-PPR replication, CrFK cells were chosen for these experiments because they have been found permissive for WT FIVpPPR protein expression and because optimal transfection protocols have been established for these cells. Immunoprecipitation of viral proteins from CrFK cultures transfected with either WT FIV-pPPR or FIV-pPPR⌬vif followed by Western blot analysis revealed comparable production of p24gag by 48 h post-transfection (Fig. 2) . Immunocytochemical staining of CrFK cultures transfected with FIV-pPPR⌬vif revealed expression of gp100env similar to that WT FIV-pPPR by 24-48 h posttransfection (Fig. 3 ). These observations indicated that expression of sequences downstream of the vif mutation (i.e., rev and env genes), as well as expression of structural proteins such as p24gag, was not affected during construction of the proviral mutant.
To confirm that the FIV-pPPR⌬vif proviral DNA construct produces replication-competent virus, transfected CrFK cells were cocultivated with PBMCs or K-258 cells, an IL-2-dependent feline lymphoid cell line, and virus production by WT and vif-mutant virus were compared. In all PBMC cocultivation experiments, p24gag production was consistently observed with the WT FIV-pPPR construct but not in PBMCs cocultivated with mock-transfected CrFK cells (Figs. 4A and 4B) . However, viral replication for the FIV-pPPR⌬vif construct varied from severely restricted (Fig. 4A ) to completely restricted ( Fig.  4B ) compared with WT in six independent experiments. Replication of Vif-mutant virus was also seen in human PBMCs cocultivated with HeLa cells transfected with HIV-1 Vif mutants (Fan and Peden, 1992) .
When K-258 cells were cocultivated with transfected CrFK cells, p24gag production was consistently observed with both WT FIV-pPPR and FIV-pPPR⌬vif constructs (Fig. 4C) ; however, the replication of the FIVpPPR⌬vif was severely attenuated compared with WT. . At 48 h after transfection, immunoprecipitations were performed on cellular extracts using FIV-infected cat sera, and the proteins were electrophoretically separated on 12% SDS-polyacrylamide gels as previously described (Sawai et al., 1996) . Immunoblot analysis was performed as described previously (Sawai et al., 1996) . Uninfected CrFK cells ( duce virus capable of cell-to-cell transmission in both PBMCs and K-258 cells.
To determine whether the FIV vif gene was required for infection of PBMCs, WT and mutant virus stocks were prepared and used to evaluate cell-free virus infectivity. Because the FIV-pPPR⌬vif virus preparation was predicted to exhibit low infectivity, infection studies were conducted using equal concentrations of virion-associated p24gag. Production of FIV p24gag was observed in PBMCs infected with WT FIV-pPPR virus by 10 days postinfection (p.i.), and replication of virus increased over time (Fig. 5) . However, productive infection was not observed from PBMCs inoculated with FIV-pPPR⌬vif throughout the time course of this study, as evidenced by lack of detection of FIV p24gag in cell culture supernatants. These results are representative of those obtained in three independent experiments. Thus, cell-free infectivity of FIV-pPPR⌬vif is markedly reduced in feline PBMCs compared with WT FIV-pPPR.
To characterize FIV-pPPR⌬vif replication in feline macrophages, MDM preparations were infected with equal concentrations of either WT FIV-pPPR or FIV-pPPR⌬vif, based on quantification of virion-associated p24gag. FIV p24gag production was observed in WT FIV-pPPR-infected MDMs by day 3 p.i. (Fig. 6 ) and increased throughout the experiment. However, culture supernatants harvested from FIV-pPPR⌬vif-infected MDMs remained negative for viral antigen for the duration of the experiment. In addition, FIV p24gag was not detected in uninfected MDM cultures. These results indicate that Vif is required for cell-free virus infectivity in feline MDMs as well as in feline PBMCs.
In this report, we cloned an FIV vif deletion mutant and characterized its replication properties in feline PBMCs and MDMs in cell culture systems. The FIV-pPPR⌬vif clone expressed viral proteins p24gag and gp100env and produced virus capable of cell-to-cell transmission on transfection of CrFK cells and cocultivation with PBMCs or K-258 cells, an IL-2-dependent feline lymphoid cell line. However, when cell-free virus preparations were used for infection studies with feline PBMCs and MDMs, FIV-pPPR⌬vif virus was incapable of productive infection. These results indicate that FIV-pPPR⌬vif exhibits a severely attenuated infectivity in both feline PBMCs and macrophages, host target cells of FIV infection in vivo. Considering that molecular clone WT FIV-pPPR establishes productive FIV infection in experimentally infected cats (Phillips et al., 1996 (Phillips et al., , 1990 Sparger et al., 1994) , FIV-pPPR⌬vif provides a valuable reagent for characterizing vif as a determinant for virus replication in vivo. In addition, inoculation of cats with FIV-pPPR⌬vif also provides another animal model for testing vif-deletion mutants as attenuated lentiviral vaccines.
MATERIALS AND METHODS

Construction of FIV-pPPR⌬vif
The FIV vif mutant clone was derived from a plasmid encoding an infectious molecular clone of FIV-designated FIV-pPPR (Phillips et al., 1990; Sparger et al., 1994) . Digestion with SauI and HindIII restriction enzymes followed by generation of blunt ends with Klenow fragment was used to create a 375-bp deletion (bases 5330-5704) within the vif gene of WT FIV-pPPR (Phillips et al., 1990) . Dideoxynucleotide sequencing confirmed the presence of the 375-bp vif deletion in the FIV-pPPR⌬vif construct (Fig. 1) . Plasmid DNA stocks were prepared by standard alkaline lysis and centrifugation to equilibrium twice in cesium chloride-ethidium bromide gradients (Sambrook et al., 1989) .
Immunoprecipitation
CrFK cells (American Type Culture Collection CCL 94) were transfected with either WT FIV-pPPR or FIVpPPR⌬vif by electroporation and cultivated as previously described using 10 g of plasmid DNA/3 ϫ 10 6 cells. By 48 h post-transfection, cell extracts were prepared from transfected cells (10 7 cells), as well as uninfected CrFK cells (negative control), and a feline lymphoid cell line chronically infected with Petaluma FIV (FL4 cells) (positive control) (Yamamoto et al., 1991) . Viral proteins were immunoprecipitated from cell extracts with FIV-infected cat sera using protocols previously described (Sawai et al., 1996) . Immunoprecipitates were analyzed for FIV p24gag expression by SDS-PAGE and Western blot analysis using a mouse monoclonal antibody specific for FIV p24gag (provided by N. C. Pedersen, University of California at Davis), as previously described (Sawai et al., 1996) . Briefly, after SDS-PAGE, proteins were transferred to a PVDF membrane that was probed using FIV p24gag-specific monoclonal antibody, and p24gag was detected using an alkaline phosphatase-conjugated rabbit anti-mouse antibody.
Immunocytochemistry
CrFK cells (1 ϫ 10 5 ) transfected with either WT FIVpPPR or FIV-pPPR⌬vif as described above were seeded onto Thermanox tissue culture slides (Nunc Inc., Naper- FIG. 5 . Replication kinetics of FIV-pPPR⌬vif-infected PBMCs. Concanavalin A-stimulated PBMCs (4 ϫ 10 6 ) were infected with WT FIVpPPR or FIV-pPPR⌬vif at 6.8 ng of virion-associated FIV p24gag or mock infected. Inocula were removed 24 h p.i., and cell culture supernatants were assayed every 3-5 days. Virus production was measured as in Fig. 2 .
FIG. 6.
Replication kinetics of FIV-pPPR⌬vif-infected MDMs. MDMs were infected with WT FIV-pPPR or FIV-pPPR⌬vif at 68 ng of virionassociated FIV p24gag or mock infected. Inocula were removed 24 h p.i., and cell culture supernatants were assayed every 3-5 days. Virus production was measured by a commercial p24gag antigen capture ELISA (IDEXX Corporation, Portland, ME).
ville, IL) from 24 to 48 h post-transfection. Uninfected CrFK cells seeded onto Thermanox tissue culture slides served as a negative control. Slides were fixed and stained for immunocytochemical analysis (Vectastain ABC kit; Vector Laboratories, Burlingame, CA) using a mouse monoclonal antibody specific for FIV gp100env (provided by C. Grant, Custom Monoclonals, West Sacramento, CA) and biotinylated horse anti-mouse IgG (Vector Laboratories) as the secondary antibody under conditions recommended by the manufacturer. Color was developed using ABC/HRP reagent and AEC substrate (Vector Laboratories).
Transfection and cocultivation
CrFK cells were transfected by electroporation, as described above. At 24 h post-transfection, CrFK cells were cocultivated with either 1.5 ϫ 10 7 PBMCs or 1 ϫ 10 7 K-258 cells in RPMI 1640 medium with 10% heatinactivated FCS, 100 IU of penicillin and 100 g of streptomycin/ml, 100 U of recombinant IL-2/ml, 50 M 2-mercaptoethanol (2-ME), and 10 mM HEPES; at 24 h after cocultivation, nonadherent cells were harvested and propagated for up to 21 days. Cell culture supernatants were collected every 3-5 days, and virus production was measured by an FIV p24gag antigen capture ELISA (Dandekar et al., 1992) .
Infection of PBMCs
WT FIV-pPPR and FIV-pPPR⌬vif virus stocks were generated as previously described (Sparger et al., 1997) , except the FIV-pPPR⌬vif virus stock was prepared by short-term passage on K-258 cells. The previously described pSV-pPPR proviral construct was used to generate the WT FIV-pPPR virus stock (Sparger et al., 1997) . Infection studies were conducted using equal concentrations of virion-associated p24gag, as determined by FIV p24gag antigen capture ELISA. Concanavalin A-stimulated feline specific pathogen-free (SPF) PBMCs (5 ϫ 10 6 ), isolated and cultivated as previously described (Sparger et al., 1994) , were plated in duplicate wells of 6-well plates and inoculated with 6.8 ng of virionassociated FIV p24gag, a viral antigen concentration equal to 100 TCID 50 of WT FIV-pPPR. Inocula were removed 24 h p.i., and cell culture supernatants were assayed for FIV p24gag by ELISA every 3-5 days for up to 18 days.
Infection of MDMs
MDM cultures were prepared by plating 10 7 freshly isolated PBMCs in RPMI 1640 medium supplemented with 10% pooled, heat-inactivated SPF cat serum and 10% heat-inactivated FCS in duplicate wells of a 24-well plate. Nonadherent cells were gently washed away with Hanks' balanced salt solution 48-72 h after plating. Adherent cells were cultured 7-10 days until confluent monolayers were formed and fed fresh media every 3-4 days. WT FIV-pPPR or FIV-pPPR⌬vif virus preparations containing 68 ng of p24gag, a concentration equal to 10 3 TCID 50 of WT FIV-pPPR, were used to infect duplicate wells of MDMs. Inocula were removed 24 h p.i., and viral replication was monitored for FIV p24gag by a commercial ELISA (IDEXX Corporation, Portland, ME) every 3-4 days up to 14 days p.i.
